Found: 6
Select item for more details and to access through your institution.
An analysis of the false negative rate of minimal residual disease measurement by multiparameter flow cytometry in multiple myeloma.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, n. 2, p. e65, doi. 10.1111/ijlh.13112
- By:
- Publication type:
- Article
Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 109, doi. 10.1111/bjh.12861
- By:
- Publication type:
- Article
The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 10, p. 765, doi. 10.1002/gcc.20899
- By:
- Publication type:
- Article
Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 2, p. 291, doi. 10.1111/bjh.12218
- By:
- Publication type:
- Article
Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 4, p. 552, doi. 10.1111/j.1365-2141.2011.08887.x
- By:
- Publication type:
- Article